Trial Profile
A phase II trial to investigate fruquintinib in combination with paclitaxel in patients with gastric cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 21 Sep 2022
Price :
$35
*
At a glance
- Drugs Fruquintinib (Primary) ; Paclitaxel
- Indications Gastric cancer
- Focus Proof of concept; Therapeutic Use
- 27 Oct 2015 New trial record
- 23 Oct 2015 The company expects to initiate this trial in early 2016, according to a Chi-Med media release.